Ovid Therapeutics Inc. is a medium-risk pharmaceutical company based in the United States of America. Specializing in rare epilepsies and seizure-related neurological disorders, Ovid Therapeutics Inc. is dedicated to developing innovative medicines aimed at reducing seizures and enhancing the quality of life for those affected. With a focus on ESG factors, the company has created a unique pipeline of treatments, including potential first-in-class drug mechanisms of action. Their epilepsy programs offer promising solutions for patients in need of effective treatment options.